Alpine Global Management’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-18,582
Closed -$67K – 179
2022
Q4
$67K Buy
+18,582
New +$79.4K 0.02% 374
2022
Q1
– Sell
-14,805
Closed -$131K – 477
2021
Q4
$131K Buy
+14,805
New +$141K 0.02% 545
2021
Q3
– Sell
-13,591
Closed -$143K – 307
2021
Q2
$143K Sell
13,591
-208,739
-94% -$2.06M 0.02% 250
2021
Q1
$2.29M Buy
222,330
+172,330
+345% +$2.4M 0.22% 74
2020
Q4
$554K Buy
+50,000
New +$510K 0.11% 90

Other funds holding SRTA

Alpine Global Management's SRTA Position: Q1 2023 in Review

Alpine Global Management sold out of Strata Critical Medical Inc (SRTA) in Q1 2023, closing a stake of 18,582 shares — an estimated $67K sold.

Alpine Global Management first reported a position in SRTA in Q4 2020 and held it in 5 quarters. The position peaked at $2.29M in Q1 2021. 93 funds tracked by Wall St. Rank hold SRTA as of Q1 2023.

  • Alpine Global Management reported no remaining Strata Critical Medical Inc position as of Q1 2023 after selling out during the quarter.
  • Alpine Global Management sold 18,582 Strata Critical Medical Inc shares in Q1 2023, an estimated $67K.
  • Alpine Global Management first reported a position in Strata Critical Medical Inc in Q4 2020 and held it in 5 quarters.
  • Alpine Global Management's Strata Critical Medical Inc position peaked at $2.29M in Q1 2021.
  • 93 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2023.

Based on Alpine Global Management's 13F filing for Q1 2023, filed 15 May 2023.